Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective

Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary cohort at a single institution. Methods: Between...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Emily Vianna, MD, Patrick R. Vargo, MD, L. Leonardo Rodriguez, MD, Salvatore Poddi, MD, Kelsey Curran, MPH, Jeevanantham Rajeswaran, PhD, Shinya Unai, MD, Eric E. Roselli, MD, Lars G. Svensson, MD, PhD, Haytham Elgharably, MD, PhD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2026-04-01
Rangatū:	JTCVS Open
Ngā marau:	INSPIRIS-RESILIA AVR SVD bioprosthesis
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2666273626000409
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!